chrX-23667754-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_006406.2(PRDX4):c.184G>A(p.Gly62Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000000911 in 1,098,055 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000089 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 9.1e-7 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control
Consequence
PRDX4
NM_006406.2 missense
NM_006406.2 missense
Scores
4
7
6
Clinical Significance
Conservation
PhyloP100: 5.26
Genes affected
PRDX4 (HGNC:17169): (peroxiredoxin 4) The protein encoded by this gene is an antioxidant enzyme and belongs to the peroxiredoxin family. The protein is localized to the cytoplasm. Peroxidases of the peroxiredoxin family reduce hydrogen peroxide and alkyl hydroperoxides to water and alcohol with the use of reducing equivalents derived from thiol-containing donor molecules. This protein has been found to play a regulatory role in the activation of the transcription factor NF-kappaB. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRDX4 | NM_006406.2 | c.184G>A | p.Gly62Arg | missense_variant | 1/7 | ENST00000379341.9 | NP_006397.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRDX4 | ENST00000379341.9 | c.184G>A | p.Gly62Arg | missense_variant | 1/7 | 1 | NM_006406.2 | ENSP00000368646.4 | ||
PRDX4 | ENST00000379331.3 | c.184G>A | p.Gly62Arg | missense_variant | 1/3 | 2 | ENSP00000368635.3 | |||
PRDX4 | ENST00000379349.5 | c.199+3036G>A | intron_variant | 3 | ENSP00000368654.1 | |||||
PRDX4 | ENST00000495599.1 | n.256G>A | non_coding_transcript_exon_variant | 1/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 1AN: 111902Hom.: 0 Cov.: 23 AF XY: 0.0000293 AC XY: 1AN XY: 34080 FAILED QC
GnomAD3 genomes
AF:
AC:
1
AN:
111902
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34080
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000552 AC: 1AN: 181035Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 66889
GnomAD3 exomes
AF:
AC:
1
AN:
181035
Hom.:
AF XY:
AC XY:
0
AN XY:
66889
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 9.11e-7 AC: 1AN: 1098055Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 363487
GnomAD4 exome
AF:
AC:
1
AN:
1098055
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
363487
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000894 AC: 1AN: 111902Hom.: 0 Cov.: 23 AF XY: 0.0000293 AC XY: 1AN XY: 34080
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1
AN:
111902
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34080
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 07, 2024 | The c.184G>A (p.G62R) alteration is located in exon 1 (coding exon 1) of the PRDX4 gene. This alteration results from a G to A substitution at nucleotide position 184, causing the glycine (G) at amino acid position 62 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Uncertain
D;T
Sift4G
Benign
T;T
Polyphen
B;.
Vest4
MutPred
Gain of catalytic residue at G62 (P = 0.0623);Gain of catalytic residue at G62 (P = 0.0623);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at